Evidence map›Paper›PMID 41924167›Full record

ArticleOrganic chemistry frontiers : an international journal of organic chemistry2026

Ligand-Enabled Hydrohydrazidation of Alkynes Catalyzed by Unsymmetrical Gold(I)-Thiazol-2-ylidenes.

Shidi Ma, Jin Zhang, Yawei Zhu, Sijie Zhou, Li Sun, Jianglong Cai, Weixi Yang, Michal Szostak

Abstract read
In one paragraph

Article in Organic chemistry frontiers : an international journal of organic chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shidi MaCollege of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an, Shaanxi 710021, China.
Jin ZhangCollege of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an, Shaanxi 710021, China.
Yawei ZhuDepartment of Chemistry, Rutgers University, 73 Warren Street, Newark, New Jersey 07102, United States.
Sijie ZhouCollege of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an, Shaanxi 710021, China.
Li SunCollege of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an, Shaanxi 710021, China.
Jianglong CaiCollege of Chemistry and Chemical Engineering, Shaanxi University of Science and Technology, Xi'an, Shaanxi 710021, China.
Weixi YangKaili Catalyst & New Materials CO., LTD, Shaanxi Key Laboratory of Catalytic Materials and Technology, Xi'an 710299, China.
Michal SzostakDepartment of Chemistry, Rutgers University, 73 Warren Street, Newark, New Jersey 07102, United States.

Funding

Catalytic Methods for Organic SynthesisR35GM133326 · NIGMS · RUTGERS THE STATE UNIV OF NJ NEWARK · PI Michal Szostak · 2019 to 2026
$2.7M
NIGMS NIH HHS R35 GM133326
6 · The paper itself

Abstract

Acyl hydrazines represent a privileged class of amide derivatives in organic synthesis and drug discovery, however, methods for effecting site-selective hydrohydrazidation remain underdeveloped. Herein, we report highly selective Au(I)-NHC-catalyzed (NHC = N-heterocyclic carbene) addition of acyl hydrazines to alkynes made feasible by the development of gold(I) complexes of "half-umbrella" shaped thiazole-derived N-heterocyclic carbenes. The method achieves broad substrate scope and functional group tolerance for the synthesis of acyl hydrazones, including highly challenging late-stage hydrohydrazidation of pharmaceuticals. Structural and extensive DFT studies demonstrate the beneficial effect of thiazol-2-ylidenes in systematic lowering of activation barriers for rate determining nucleophilic addition and proton transfer steps. The study provides an efficient approach to privileged hydrazide motifs and establishes thiazolium-derived carbenes as highly effective catalysts in gold-catalyzed π-activation chemistry.

Identifiers

PMID41924167
PMCPMC13038307

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.